UCSF researchers are the first to demonstrate that the approach works for the patients who

March 6, 2025 No Comments

German company, InflaRx, has developed an investigational therapy, Vilobelimab, which is being studied for SARS-CoV-2-induced

March 6, 2025 No Comments

Image credits: Vaxart Inc Vaxart, Inc announced the publication of complete data from its Phase

March 6, 2025 No Comments

On Tuesday, the Texas Department of State Health Services provided an update on the measles

March 6, 2025 No Comments

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2

March 5, 2025 No Comments

Invivyd’s Chief Scientific Officer Robert Allen, PhDImage credit: Invivyd Today, Waltham, Mass.-based biopharmaceutical company,Invivyd, announced

March 5, 2025 No Comments

The FDA has paused BioNTech’s Phase I/IIa trial of its experimental malaria vaccine, BNT165e, due

March 5, 2025 No Comments

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed)

March 5, 2025 No Comments

A large clinical trial in Burkina Faso found that repeated high-dose ivermectin mass drug administration

March 5, 2025 No Comments

Oliver Cornely Image credits: CECAD Cologne A new global guideline for management of candidiasis includes

March 5, 2025 No Comments

Schedule an Appointment

Quick Links